化合物详情
CAS1271-24-5
分子式Cr(C5H5)2
分子量182.18 g/mol g/mol
危化品
Physical Description | Bis(cyclopentadienyl)chromium appears as red needles or reddish-purple solid. (NTP, 1992)
科学粮草官-词典编辑部,修订于:2026-07-06
暂无结构图
Toxicity
ToxicitySymptoms
Chromium in its trivalent state is not very toxic, but it may be oxidized to hexavalent chromium. Breathing hexavalent chromium can cause irritation to the lining of the nose, nose ulcers, runny nose, and breathing problems, such as asthma, cough, shortness of breath, or wheezing. Ingestion of hexavalent chromium causes irritation and ulcers in the stomach and small intestine, as well as anemia. Skin contact can cause skin ulcers. (L16)
Treatment
There is no know antidote for chromium poisoning. Exposure is usually handled with symptomatic treatment. (L16)
Health Effects
Chromium in its trivalent state is not very toxic. It may be oxidized to hexavalent chromium, a known carcinogen. Hexavalent chromium has also been shown to affect reproduction and development. (A12)
Exposure Routes
Oral (L16); inhalation (L16); dermal (L16)
Toxicity Summary
Trivalent chromium may also form complexes with peptides, proteins, and DNA, resulting in DNA-protein crosslinks, DNA strand breaks, DNA-DNA interstrand crosslinks, chromium-DNA adducts, chromosomal aberrations and alterations in cellular signaling pathways. It has been shown to induce carcinogenesis by overstimulating cellular regulatory pathways and increasing peroxide levels by activating certain mitogen-activated protein kinases. It can also cause transcriptional repression by cross-linking histone deacetylase 1-DNA methyltransferase 1 complexes to CYP1A1 promoter chromatin, inhibiting histone modification. Chromium may increase its own toxicity by modifying metal regulatory transcription factor 1, causing the inhibition of zinc-induced metallothionein transcription. (A12, L16, A34,...
Carcinogen Classification
No indication of carcinogenicity (not listed by IARC). (L135)





